N. Deconinck and B. Dan, Pathophysiology of Duchenne Muscular Dystrophy: Current Hypotheses, Pediatric Neurology, vol.36, issue.1, pp.1-7, 2007.
DOI : 10.1016/j.pediatrneurol.2006.09.016

M. Koenig, P. E. Hoffman, J. C. Bertelson, P. A. Monaco, C. Feener et al., Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals, Cell, vol.50, issue.3, pp.509-517, 1987.
DOI : 10.1016/0092-8674(87)90504-6

O. Ibraghimov-beskrovnaya, M. J. Ervasti, J. C. Leveille, A. C. Slaughter, W. S. Sernett et al., Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix, Nature, vol.355, issue.6362, pp.696-702, 1992.
DOI : 10.1038/355696a0

G. Bulfield, G. W. Siller, A. P. Wight, and J. Moore, X chromosome-linked muscular dystrophy (mdx) in the mouse., Proceedings of the National Academy of Sciences, vol.81, issue.4, pp.1189-1192, 1984.
DOI : 10.1073/pnas.81.4.1189

H. H. Stedman, L. H. Sweeney, B. J. Shrager, C. H. Maguire, A. R. Panettieri et al., The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy, Nature, vol.352, issue.6335, pp.536-539, 1991.
DOI : 10.1038/352536a0

G. J. Tidball and M. Wehling-henricks, The role of free radicals in the pathophysiology of muscular dystrophy, Journal of Applied Physiology, vol.102, issue.4, pp.1677-1686, 2007.
DOI : 10.1152/japplphysiol.01145.2006

X. Y. Yang, M. M. Muqit, and S. Latchman, Induction of parkin expression in the presence of oxidative stress, European Journal of Neuroscience, vol.101, issue.5, pp.1366-1372, 2006.
DOI : 10.1111/j.1460-9568.2006.04998.x

Y. Ito, S. Oumi, T. Nagasawa, and N. Nishizawa, Oxidative Stress Induces Phosphoenolpyruvate Carboxykinase Expression in H4IIE Cells, Bioscience, Biotechnology, and Biochemistry, vol.52, issue.5, pp.2191-2198, 2006.
DOI : 10.1021/jf0202133

M. Jamaluddin, S. Wang, I. Boldogh, B. Tian, and R. Brasier, A: TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway, Cell Signal: NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alphainduced chondrocytes, pp.1419-33367, 2006.

F. H. Kramer, J. L. Goodyear, . Exercise, N. Mapk, S. Messina et al., Exercise, MAPK, and NF-??B signaling in skeletal muscle, Journal of Applied Physiology, vol.103, issue.1, pp.388-95918, 2006.
DOI : 10.1152/japplphysiol.00085.2007

A. Kumar, S. Lnu, R. Malya, D. Barron, J. Moore et al., Mechanical stretch activates nuclear factor-kappaB, activator protein-1, and mitogen-activated protein kinases in lung parenchyma: implications in asthma, The FASEB Journal, vol.17, issue.13, pp.1800-1811, 2003.
DOI : 10.1096/fj.02-1148com

A. Kumar and M. Boriek, Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy, The FASEB Journal, vol.17, issue.3, pp.386-396, 2003.
DOI : 10.1096/fj.02-0542com

C. M. Monici, M. Aguennouz, A. Mazzeo, C. Messina, and G. Vita, Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy, pp.993-997, 2003.

J. Stuerenburg, H. Jung, R. Schoser, and G. , Age effects on interleukin-6 and interleukin-1?? responses to endurance exercise in patients with neuromuscular diseases, Archives of Gerontology and Geriatrics, vol.29, issue.1, pp.21-27, 1999.
DOI : 10.1016/S0167-4943(99)00018-7

J. W. Durham, S. Arbogast, E. Gerken, P. Y. Li, and B. Reid, Progressive nuclear factor-??B activation resistant to inhibition by contraction and curcumin inmdx mice, Muscle & Nerve, vol.277, issue.3, pp.298-303591, 2006.
DOI : 10.1002/mus.20579

D. J. Archer, C. C. Vargas, and E. Anderson, Persistent and improved functional gain in mdx dystrophic mice after treatment with L-arginine and deflazacort, The FASEB Journal, vol.20, pp.738-740, 2006.
DOI : 10.1096/fj.05-4821fje

D. Chazalette, K. Hnia, F. Rivier, G. Hugon, and D. Mornet, -arginine administration, FEBS Letters, vol.5, issue.5, pp.1079-1084, 2005.
DOI : 10.1016/j.febslet.2004.12.081

URL : https://hal.archives-ouvertes.fr/hal-00663396

D. Luca, A. Nico, B. Liantonio, A. Didonna, P. M. Fraysse et al., A Multidisciplinary Evaluation of the Effectiveness of Cyclosporine A in Dystrophic Mdx Mice, The American Journal of Pathology, vol.166, issue.2, pp.477-489, 2005.
DOI : 10.1016/S0002-9440(10)62270-5

A. Briguet, I. Courdier-fruh, M. Foster, T. Meier, and P. Magyar, Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse, Neuromuscular Disorders, vol.14, issue.10, pp.675-682, 2004.
DOI : 10.1016/j.nmd.2004.06.008

C. Heussen and B. Dowdle, Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates, Analytical Biochemistry, vol.102, issue.1, pp.196-202, 1980.
DOI : 10.1016/0003-2697(80)90338-3

K. Hnia, G. Hugon, A. Masmoudi, J. Mercier, F. Rivier et al., Effect of betadystroglycan processing on utrophin/Dp116 anchorage in normal and mdx mouse Schwann cell membrane, pp.607-620, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00143214

J. Wilson, W. Putt, C. Jimenez, Y. Edwards, K. Hnia et al., Up71 and Up140, two novel transcripts of utrophin that are homologues of short forms of dystrophin, Human Molecular Genetics, vol.8, issue.7, pp.1271-1278, 1999.
DOI : 10.1093/hmg/8.7.1271

E. Chaubourt, V. Voisin, P. Fossier, G. Baux, M. Israel et al., The NO way to increase muscular utrophin expression?, Comptes Rendus de l'Acad??mie des Sciences - Series III - Sciences de la Vie, vol.323, issue.8, pp.735-740, 2000.
DOI : 10.1016/S0764-4469(00)01219-1

URL : https://hal.archives-ouvertes.fr/hal-00171804

V. Voisin, C. Sebrie, S. Matecki, H. Yu, B. Gillet et al., -arginine improves dystrophic phenotype in mice, Neurobiology of Disease, vol.20, issue.1, pp.123-1302587, 2002.
DOI : 10.1016/j.nbd.2005.02.010

URL : https://hal.archives-ouvertes.fr/in2p3-01009308

M. J. Lang, A. K. Esser, and E. Dupont-versteegden, Altered activity of signaling pathways in diaphragm and tibialis anterior muscle of dystrophic mice, Exp Biol Med, vol.229, pp.503-511, 2004.

A. Kumar, Y. Takada, M. A. Boriek, and B. Aggarwal, B: Nuclear factor-kappaB: its role in health and disease, J Mol Med, vol.82, pp.434-448, 2004.

A. Kumar, N. Khandelwal, R. Malya, B. M. Reid, and M. Boriek, Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers, The FASEB Journal, vol.18, issue.1, pp.102-113, 2004.
DOI : 10.1096/fj.03-0453com

J. , K. , M. Tidball, G. J. Baldwin, S. A. Guttridge et al., D: Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy M: Cellular and molecular regulation of muscle regeneration, J Clin Invest Physiol Rev, vol.117, issue.84, pp.889-901209, 2004.

M. Karin and Y. Ben-neriah, Phosphorylation Meets Ubiquitination: The Control of NF-??B Activity, Annual Review of Immunology, vol.18, issue.1, pp.621-663, 2000.
DOI : 10.1146/annurev.immunol.18.1.621

C. D. Guttridge, W. M. Mayo, V. L. Madrid, Y. C. Wang, S. A. Baldwin et al., NF-kappa B-Induced Loss of MyoD Messenger RNA: Possible Role in Muscle Decay and Cachexia, Science, vol.289, issue.5488, pp.2363-2366, 2000.
DOI : 10.1126/science.289.5488.2363

A. Pisconti, S. Brunelli, D. Padova, M. Palma, D. et al., Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion, The Journal of Cell Biology, vol.81, issue.2, pp.233-244, 2006.
DOI : 10.1074/jbc.M413550200

B. I. Buchwalow, A. E. Minin, U. F. Muller, G. Lewin, E. V. Samoilova et al., Nitric oxide synthase in muscular dystrophies: a re-evaluation, Acta Neuropathologica, vol.90, issue.1, pp.579-588, 2006.
DOI : 10.1007/s00401-006-0069-5

H. R. Crosbie, V. Straub, Y. H. Yun, C. J. Lee, A. J. Rafael et al., mdx muscle pathology is independent of nNOS perturbation, Human Molecular Genetics, vol.7, issue.5, pp.823-829, 1998.
DOI : 10.1093/hmg/7.5.823

W. Zhuang, C. J. Eby, M. Cheong, K. P. Mohapatra, S. D. Bredt et al., The susceptibility of muscle cells to oxidative stress is independent of nitric oxide synthase expression, Muscle & Nerve, vol.270, issue.4, pp.502-511, 2001.
DOI : 10.1002/mus.1033

F. Mariotti, J. Huneau, I. Szezepanski, K. Petzke, Y. Aggoun et al., Meal amino acids with varied levels of arginine do not affect postprandial vascular endothelial function in healthy young men, J Nutr, vol.137, pp.1383-1389, 2007.

M. J. Gillis, S. Ebihara, H. G. Guibinga, R. Gilbert, J. Nalbantoglu et al., An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice B: Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice, Acta Neurol Belg Physiol Genomics, vol.100, issue.3, pp.146-150, 2000.

M. Neri, S. Torelli, S. Brown, I. Ugo, P. Sabatelli et al., Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human, Neuromuscular Disorders, vol.17, issue.11-12, pp.913-918, 1999.
DOI : 10.1016/j.nmd.2007.07.005

K. Hnia, D. Zouiten, S. Cantel, D. Chazalette, G. Hugon et al., ZZ domain of dystrophin and utrophin: topology and mapping of a ??-dystroglycan interaction site, Biochemical Journal, vol.401, issue.3, pp.667-677, 2007.
DOI : 10.1042/BJ20061051

URL : https://hal.archives-ouvertes.fr/hal-00478628